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Abstract
Introduction Alexander disease is a rare disorder of the
central nervous system with characteristic symmetric white
matter abnormalities with frontal predominance on mag-
netic resonance (MR) images. Histopathology shows a lack
of myelin in the affected white matter, variably interpreted
as hypomyelination or demyelination. To increase our
insight into the nature of the pathology leading to the MR
imaging findings in Alexander disease, we applied serial
MR imaging, spectroscopy, magnetization transfer (MT)
imaging (MTI), and diffusion tensor imaging (DTI) in six
patients with juvenile Alexander disease.
Methods The MR imaging protocol comprised T1- and T2-
weighted spin echo images and fluid-attenuated inversion
recovery images. Fractional anisotropy (FA), apparent
diffusion coefficient (ADC), and MT ratio (MTR) maps
were generated, and MR spectroscopy concentrations were
quantified for several metabolites.
Results MR imaging showed similar cerebral white matter
abnormalities in all patients, with only minor increase on
prolonged follow-up, despite sometimes serious clinical
progression. MR spectroscopy showed highly elevated
levels of myo-inositol, lactate, and choline-containing
compounds and decreased total N-acetyl-aspartate and N-
acetyl-aspartyl-glutamate levels in the abnormal white
matter. High values of ADC were observed, and both FA
and MTR were attenuated.
Conclusion ThesequentialMRimagingfindingsinAlexander
disease provide strong evidence against active demyelination
as soleexplanationfor theunderlyingpathology.Analternative
explanation for our spectroscopic, DTI, and MTI findings—
which would suggest demyelination—could be hyperplasia
and hypertrophy of astrocytes, as seen in low grade gliomas.
Keywords Whitematter.Alexander disease.
Quantitative magneticresonanceimaging
Introduction
Alexander disease is a rare disorder of the central nervous
system. Dominant, usually de novo, mutations in the gene
GFAP, encoding the glial fibrillary acidic protein (GFAP),
have been identified in patients with histopathologically
proven Alexander disease [1, 2]. Three clinical subgroups
can be distinguished: infantile, juvenile, and adult. The
most common form is the infantile form, which presents as
a progressive leukodystrophy with developmental delay,
seizures, macrocephaly, spasticity, and rapid deterioration
with early demise. The juvenile and adult variants have a
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a consistent finding. Bulbar symptoms are almost invari-
ably present [1, 2].
Characteristic diagnostic magnetic resonance (MR)
imaging (MRI) criteria have been proposed, including
symmetric white matter abnormalities with frontal predom-
inance, a periventricular rim with high signal on T1-
weighted images and low signal on T2-weighted images,
abnormalities of the basal ganglia and thalami, brainstem
lesions, and contrast enhancement of particular gray and
white matter structures [3]. Since the presence of a
pathogenic mutation in the GFAP mutation has become
the gold standard for the diagnosis of Alexander disease, it
has become clear that the MR imaging picture is much
more variable than initially thought. Especially in juvenile
and adult cases of Alexander disease, the leukoencephal-
opathy with frontal preponderance may be missing and the
brain stem involvement may dominate, often with multifocal
tumor-like lesions [4, 5].
Neuropathologically, the most distinctive feature of
Alexander disease is the presence of massive numbers of
Rosenthal fibers, which accumulate in astrocytes. Rosenthal
fibers are scattered throughout the white matter in all areas
of the brain, but are most intense in subependymal, subpial,
and perivascular locations. Astrocytic density is increased
in the same areas. Another distinctive feature is the paucity
of myelin, generally most pronounced in the frontal white
matter, variably interpreted as hypomyelination or demye-
lination. The axons appear intact in those areas, suggesting
a lack of myelin deposition. However, infiltrating macro-
phages with perivascular lymphocytic cuffs may also occur,
suggesting a component of active demyelination [6, 7]. The
nature of the white matter pathology is therefore not clear.
Previously, a method was developed to discriminate between
varioustypesofwhitematterpathologythataffectchildren,such
as demyelination, hypomyelination, myelin vacuolation, and
cystic degeneration, using quantitative MR parameters [8]. To
increase our understanding of the pathophysiological mecha-
nisms leading to the MR findings in juvenile Alexander
disease, we conducted MR spectroscopy, magnetization
transfer (MT) imaging (MTI), and diffusion tensor imaging
(DTI) in six patients with juvenile Alexander disease.
Materials and methods
Patients and control subjects
This study was performed with the informed consent of the
patients and control subjects or of their parents and with the
approval of the institutional ethics review board.
We included three boys and three girls with juvenile
Alexander disease. In all six patients, the diagnosis of
Alexander disease was confirmed by the demonstration of a
heterozygous de novo mutation (i.e., not detected in DNA of
the parents) in the GFAP gene (Table 1).
In three patients, all quantitative measures were obtained
on at least one occasion. One patient was studied with the
same protocol, but without DTI. Two patients underwent
conventional MRI only (without DTI and MTI) and MRS,
but another MRS technique was used which did not allow
quantification. The ages of the patients ranged from 3.3 to
19.9 years at the MR investigations that were used for
quantitative measurements.
Quantitative MR imaging and spectroscopy results of the
patients were compared with the results of control subjects
(25 males, 16 females; age range 2.0 to 26.4 years).
Overall, the most rapid changes in values of quantitative
MRI parameters and MRS metabolites occur during the
first 2 years and close to final values are reached at the age
of 2 years, when myelination is almost complete [9–11]. To
avoid a significant influence of age-dependent changes,
only patients and control subjects of 2 years and older were
included.
The control subjects were either healthy volunteers or
pediatric subjects with normal results at neurologic exam-
ination and normal MRI results. The latter subjects
underwent MRI for reasons like headache and epileptic
seizures.
MR imaging and proton MR spectroscopy
All examinations were performed on a 1.5-T MR scanner
(Siemens Vision, Erlangen, Germany). The conventional
imaging protocol included sagittal T1-weighted images
using a three-dimensional (3D) magnetization-prepared
rapid acquisition gradient-echo sequence (repetition time
(TR) 15 ms, echo time (TE) 4 ms, one excitation),
transverse T2-weighted spin echo images (TR 3,000 ms,
TE 22, 60, and 120 ms, one excitation), and coronal or
transverse fluid-attenuated inversion recovery (FLAIR)
images (TR 9,000 ms, TE 105 ms, inversion time
2,200 ms, one excitation). All MRIs were reviewed by
Table 1 De novo GFAP mutations in six patients with Alexander
disease.
Patient/gender GFAP mutation
1/M c.715C>T p.Arg239Cys
2/M c.716G>C p.Arg239Pro
3/M c.703T>C p.Leu235Pro
4/F c.1121A>G p.Glu374Gly
5/F c.262C>T p.Arg88Cys
6/F c.715C>T p.Arg239Cys
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were analyzed for localization, extent, and appearance of
the cerebral white matter abnormalities in order to compare
these findings to the quantitative MR parameters, as
described below.
DTI was performed in three patients (patients 2, 4, and 5)
on several occasions with a multislice echo planar imaging
(EPI) sequence with optimized gradients according to the
method described by Jones et al. [12] using a reference
b=0 s/mm
2 and eight noncollinear gradient vectors with
b=1,044 s/mm
2.I nt r a n s v e r s eo r i e n t a t i o n ,1 6s l i c e so f5m m
were acquired, with a 128×128 matrix, using TR=3,600 ms
and TE=123 ms. The DTI analysis included a correction of
eddy current-induced distortion and calculation of eigenvalues
ofthediffusiontensor, resulting ina fractionalanisotropy (FA)
map and an apparent diffusion coefficient (ADC) map. In
patient 2 at age 15 years 7 months, no DTI but only diffusion-
weighted imaging was performed, usingan EPI sequencewith
b values of 0, 500, and 1,000 s/mm
2 (TR 5,100 ms, TE
137 ms), yielding an automatically generated ADC map (but
no FA map).
MTI wasperformedinfourpatients(patients 1,2,4,and5)
on several occasions with a 3D fast low-angle shot sequence.
T wosetsofimageswereobtainedwith(MS) and without (M0)
MT saturation pulse (7.68 ms Gaussian radio frequency
pulse, 1,500 Hz off-resonance), using TR=23 ms, TE=4 ms,
flip angle 20°, and a 3D slab consisting of 54 transverse
slices of 3 mm. MT ratio (MTR) maps were created
according to MTR=1−MS/M0.
Quantitative MR spectroscopy was performed in four
patients (patients 1, 2, 4, and 5) using a short-echo time
stimulated echo acquisition mode (STEAM) sequence (TR/
TE/mixing time=6,000/20/10 ms, 64 accumulations).
Single-acquisition reference measurements without water
suppression were acquired additionally to enable eddy
current correction. Spectra were acquired from one or two
volumes of interest (VOIs; 4–6 ml) within parietal and/or
frontal white matter (in case of patients, all in affected
white matter). The VOIs were positioned on the conven-
tional MR images, taking care to avoid or minimize
contamination by cerebrospinal fluid and gray matter.
Metabolite concentrations were calculated using LCModel
[13] and expressed as millimoles per liter VOI. Concen-
trations were determined for the metabolites total creatine
and phosphocreatine (tCr), total N-acetyl-aspartate and
N-acetyl-aspartyl-glutamate (tNAA), choline-containing
compounds (Cho), myo-inositol (Ins), and lactate (Lac).
MR spectroscopy in the other two patients (patients 3 and
6) had been performed with STEAM sequence as well (TR
2,500 ms), but before regular calibration of the scanner for
absolute quantification was performed. The changes in
MRS metabolites were observed qualitatively in these two
patients.
Regions of interest (ROIs) corresponding to the MR
spectroscopy VOIs were transferred to the equivalent ADC,
FA, and MTR maps and mean ADC, FA, and MTR in these
ROIs were determined. Mean values ± standard deviations
were determined for the patients and controls.
Classification
The discriminant functions for four white matter disease
groups (hypomyelination, demyelination, myelin vacuola-
tion, and cystic degeneration) from the linear discriminant
analysis, given in the appendix of a previously published
paper [8], were used to determine into which group the
patients who underwent all quantitative investigations
(patients 2, 4, and 5) were classified when seven MR
parameters (MTR, ADC, tCr, tNAA, Cho, Ins, and Lac)
were substituted into these functions.
Results
MRIs (ages 3 and 6 years) in patient 1 showed symmetric
signal abnormalities in the cerebral white matter, with mild
swelling and frontal predominance. Despite serious clinical
deterioration and demise soon after the second MRI, the
white matter abnormalities showed only minor increase
(Fig. 1a, b). In patient 2, the initial MRI at the age of
2 years showed signal abnormalities in the periventricular
and deep cerebral white matter without swelling and
without frontal predominance. During a follow-up of
18 years, during which the patient clinically remained
remarkably stable, the frontal white matter abnormalities
showed some increase and became more marked than the
parieto-occipital white matter abnormalities, although the
cerebral white matter abnormalities remained limited in
their extent in all areas. In patient 3, three MRI studies
(ages 6–10 years) showed bilateral frontal white matter
abnormalities with swelling (Fig. 1c, d). The only change
regarding the white matter abnormalities over time was that
the FLAIR images revealed a progressive decrease of signal
intensity, indicating white matter rarefaction and cystic
degeneration. During this time, the patient deteriorated
seriously and died shortly after the third MRI. In patient 4,
three MRI studies (4–8 years) demonstrated extensive
cerebral white matter abnormalities with swelling and
frontal preponderance. FLAIR images show evidence of
white matter rarefaction and cystic change. Over time, the
cerebral white matter signal abnormalities showed some
increase in extent. The most marked change was progres-
sive white matter atrophy with secondary dilatation of the
lateral ventricles. This patient showed moderate clinical
deterioration during this time. In patient 5, extensive areas
of abnormal signal in the white matter were found on MRI
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MRI after 2 years was unchanged. The patient was
clinically stable. MRI in patient 6 revealed symmetric
frontal white matter abnormalities almost restricted to the
frontal and parietal lobes at 4 years. After 1 year, only some
increase in white matter swelling was observed. This
patient experienced serious clinical deterioration and died.
A total of 17 MRS measurements were obtained in the
abnormal white matter of the four patients, six in the (most
affected) frontal white matter and 11 in the parietal white
matter. A proton MR spectrum of patient 5 is depicted in
Fig. 2 for frontal white matter. The quantified metabolite
concentrations of patients 1, 2, 4, and 5 are shown in
Table 2. Main findings were a marked reduction of the
concentration of tNAA in both frontal and parietal regions
(progressive over time), a strong elevation of the concen-
trations of Ins (increasing over time in most patients) in
both regions, and accumulation of Lac in all patients.
Furthermore, Cho concentrations were strongly elevated in
most measurements. The level of tCr was elevated when Ins
was increased. Similar spectroscopic changes were ob-
served qualitatively in patients 3 and 6, in whom we did not
have the possibility of quantification of the metabolite
concentrations.
A total of eight MTI and five DTI measurements were
obtained in the white matter of the patients. Examples of
MTR, ADC, and FA maps that were obtained in patient 5
are shown in Fig. 2. MTR, ADC, and FA values in ROIs
corresponding to the spectroscopy VOIs are shown in
Table 2. In the white matter of all Alexander patients, high
values of ADC were observed, and both FA and MTR were
attenuated. Although overall ADC is increased in affected
white matter, we observed some regional heterogeneity. In
patients 4 and 5, a thin periventricular rim of lowered ADC
values was observed in the parietal white matter (Fig. 2b).
Substituting the seven quantitative MR parameters MTR,
ADC, tCr, tNAA, Cho, Ins, and Lac as measured in the
frontal or parietal regions for patients 2, 4, and 5 in the
discriminant functions for the four white matter disease
groups of the linear discriminant analysis [8] resulted in
classification of these patients into the demyelination group
in all patients at each time point.
Discussion
The nature of the pathology underlying the white matter
abnormalities in Alexander disease is not clear. Histopa-
thology shows a lack of myelin in the affected white matter,
variably interpreted as hypomyelination or demyelination
[6, 7]. In this study, we applied serial MRI to visualize
structural abnormalities, proton MR spectroscopy to assess
metabolic abnormalities, and MTI and DTI to determine
MTR, ADC, and FA values in the white matter of several
patients with juvenile Alexander disease in order to obtain
better insight into the nature of the pathology.
MR spectroscopy showed highly elevated Ins, Lac, and
Cho levels and decreased tNAA levels in our patients. In
the context of a white matter disorder, such findings are
generally interpreted as suggestive of active demyelination
[14–16]. Multiple studies in demyelinating diseases have
reported that MR spectroscopy of the affected white matter
is characterized by decreased NAA and elevated Cho, Ins,
and Lac [14–16]. These metabolic changes are interpreted
as evidence of axonal damage or loss, enhanced membrane
turnover or accumulation of myelin breakdown products or
both, astrogliosis, and infiltrating macrophages, respectively
[14–16]. In addition, we found high ADC and decreased
MTR an FA values in the abnormal white matter.
We applied discriminant functions determined in a
previously published paper [8], in which pathophysiological
mechanisms underlying white matter diseases were classified
into four categories using quantitative MR parameters:
demyelination, hypomyelination, myelin vacuolation, and
cystic degeneration. With this method, the white matter
Fig. 1 Transverse T2-weighted images (3,000/22, 60 and 120, one
excitation) in two patients. MRIs at ages 3 (a) and 6 years (b)i n
patient 1 showed symmetric signal abnormalities in the cerebral white
matter, with mild swelling and a frontal predominance. The white
matter abnormalities showed only minor increase on follow-up. In
patient 3, two MRI studies at age 8 (c) and 10 years (d) showed little
change in the bilateral frontal white matter abnormalities with swelling
672 Neuroradiology (2009) 51:669–675Fig. 2 VOI localization for
MRS (STEAM TR/TE/TM=
6,000/20/10 ms, 64 accumula-
tions) on the transverse
T2-weighted image (a) (3,000/
22, 60 and 120, one excitation),
and equivalent transverse ADC
(b), FA (c), and MTR (d) maps
with the corresponding spectrum
(e) in patient 5: high ADC,
decreased FA and MTR, and a
decrease in tNAA and increases
in Cho, Ins, and Lac are evident.
Note focal areas of lowered
ADC values in the parietal white
matter
Table 2 MTR (%), ADC (10
−3mm
2/s), and FA values and metabolite concentrations (mmol/L) in white matter regions of patients and controls
(mean ± standard deviation).
Patient Sex Age Region MTR ADC FA tCre tNAA Cho Ins Lac
1 M 3 years 3 months LF 4.3 3.7 1.6 4.2 1.3
LP 6.5 4.7 2.5 5.7 0.8
6 years 6 months LF 21.4 4.8 1.9 2.0 5,5 0,9
LP 25.2 6.1 2.7 2.6 5.9 1.9
2 M 12 years 2 months LP 6.2 2.8 2.9 9.2 2.7
14 years 5 months LP 28.4 6.7 4.0 2.5 9.0 2.2
15 years 7 months LF 2.35 3.7 2.5 1.4 5.2 2.0
LP 1.55 5.6 2.8 2.5 7.4 2.0
18 years 9 months LP 25.1 6.2 3.3 2.0 9.6 1.0
19 years 11 months LP 23.3 1.05 0.27 5.6 3.5 2.4 9.3 1.2
4 F 4 years RF 14.2 2.27 0.21 3.6 1.8 1.5 6.3 1.1
LP 19.1 1.75 0.25 4.8 2.4 1.8 5.0 8.5
5 years 10 months RF 13.7 2.33 0.16 3.4 0.7 1.3 6.8 2.9
LP 17.9 2.05 0.17 4.4 1.9 1.9 6.3 4.4
8 years 2 months LP 15.2 2.12 0.17 4.1 1.5 2.3 8.6 4.4
5 F 7 years 5 months LF 20.9 1.60 0.13 5.9 3.9 2.5 9.3 4.7
LP 23.7 1.24 0.19 6.6 4.3 2.9 9.7 5.2
Controls LP 31.4±2.1 0.91±0.12 0.34±0.05 4.5±0.5 7.5±0.8 1.4±0.2 3.5±0.5 0.4±0.4
LF left frontal, RF right frontal, LP left parietal
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demyelination rather than hypomyelination.
Conventional MRI showed cerebral white matter abnor-
malities with frontal preponderance in our patients, the
extent of which was remarkably stable on follow-up, even
at prolonged follow-up, irrespective of the clinical progres-
sion of the disease, which was serious in some cases. This
finding is in line with previous MRI studies on Alexander
disease [17, 18] and, in fact, not compatible with active
demyelination as sole cause of the clinical deterioration and
the white matter abnormalities on MRI. In diseases
characterized by active demyelination, for instance meta-
chromatic leukodystrophy and X-linked adrenoleukodys-
trophy, in which the aforementioned MR spectroscopic
abnormalities are typically found [15–18], MRI reveals that
the extent of the white matter abnormalities increases over
time, sometimes rapidly. Therefore, sequential MRI in
juvenile Alexander disease provides strong evidence
against active demyelination as sole pathophysiological
mechanism, although, of course, we cannot exclude the
possibility of low-grade myelin loss as part of the
pathology.
The question is what the alternative explanation could be
for our spectroscopic findings. It should be noted that MR
spectra supposedly suggestive of demyelination are also
observed in low-grade gliomas [19]. The decreased density
or dysfunction of axons in these tumors is reflected in low
NAA. The increased membrane density and turnover is
reflected in increased Cho. Ins is mainly present in
astrocytes and with that increased in tumors of increased
glial density. Elevated Lac in gliomas is explained by the
reduced oxygenation by impaired blood flow within the
tumor. The question is whether gliomas and Alexander
disease may have something in common.
Alexanderdiseaseisadiseaseofastrocytes.Histopathology
of the affected white matter demonstrates proliferation and
hypertrophyofastrocytesthataccumulateRosenthalfibers[7].
The disease is not so different from a circumscribed or
diffusely infiltrating low-grade glioma. Some patients with
Alexander disease actually display tumor-like lesions, espe-
cially in the brain stem, but sometimes also elsewhere [20].
The pathologic similarities between Alexander disease and
gliomas may be so striking that diagnostic problems arise,
especially in focal brain stem tumors, also because some low-
grade gliomas, for example in a pilocytic astrocytoma, may
contain Rosenthal fibers. However, despite some intriguing
similarities, pseudotumoral forms of Alexander disease are
“self-limiting” and ultimately regressive leading to atrophy,
unlike true neoplastic processes.
The MR spectroscopic findings in Alexander disease
allow an alternative interpretation. The marked Ins eleva-
tion can be ascribed to the hyperplasia and hypertrophy of
astrocytes. The elevation of Cho can be ascribed to
increased membrane density of the affected white matter.
The elevated lactate in the affected white matter, observed
in all our patients, could be related to metabolic disruption
of disordered astrocytes giving rise to nonoxidative
glycolysis [19].The low NAA can be explained by the
decreased density of nerve fibers in the swollen white
matter full of astrocytes.
MTR and DTI provide information about tissue microstruc-
ture. The MTR in the white matter of our patients was
decreased, indicatinga reducedcapacity of themacromolecule-
bound protons in brain tissue to exchange magnetization with
the surrounding protons in free water, probably reflecting lack
of myelin and damage of axonal membranes. Within the
abnormal white matter, ADC, a measure for water diffusivity,
irrespective of direction, was increased in patients, and FA, a
measure for the degree of diffusion anisotropy, was decreased.
Both observations in white matter indicate damage to the tissue
matrix. So far, the findings are as seen in other leukoencepha-
lopathies [8]. Interestingly, however, we observed decreased
ADC values in a periventricular rim in the parietal region in
two patients. This may be explained by a high density of
astrocytes stuffed with Rosenthal fibers, which are preferen-
tially located in the periventricular white matter, which would
hamper the diffusion. Similarly, it is known that diffusion is
restricted in gliomas with increased cellularity [21].
A limitation of our study is the rather small number of
patients and MR studies, which is related to the rarity of the
diseases. This precludes analysis of changes over time for
MTR, ADC, and FA values and MRS metabolite concen-
trations. It should also be noted that we only investigated
patients with the juvenile form of the disease. The results of
our study may not be applicable to all forms of the disease.
In the infantile form, myelin build-up may be predomi-
nantly affected, leading to hypomyelination, whereas in
adult forms, the cerebral white matter is often normal.
Conclusion
In conclusion, the results of our study suggest that
abnormalities of the white matter in juvenile Alexander
disease are not related to active demyelination, although we
cannot exclude minor low-grade demyelination as part of
the pathology. Hyperplasia and hypertrophy of astrocytes
with Rosenthal deposition probably explain the MR
spectroscopic findings.
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